Stephen W. Wright - Concepedia

Author

Stephen W. Wright

Also Known As

Fatima Maria De Souza Moreira, Fatima Maria de Souza Moreira, Peter Morin, Pierre Chambon, S Wright, S. W. WRIGHT, S. W. Wright, S.W. Wright, Stephen W. Wright, Stephen W WRIGHT

206

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Wilmington University Harvard University

About

Stephen W. Wright is an author at Pfizer (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	572
2	Biochemistry	16	21	953
3	Natural Sciences	15	19	893
4	Engineering	12	13	431
5	Health Sciences	1	1	19

Stephen W. Wright

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Fluoride-Mediated Boronic Acid Coupling Reactions Stephen W. Wright, David Hageman, Lester D. McClure The Journal of Organic Chemistry Cross-coupling ReactionMolecular SciencesBiochemistryDonut IconNatural Sciences	1994	317
A Convenient Preparation of Heteroaryl Sulfonamides and Sulfonyl Fluorides from Heteroaryl Thiols Stephen W. Wright, Kelly N. Hallstrom The Journal of Organic Chemistry HalogenationHeteroaryl ThiolsChemical EngineeringEngineeringHeterocyclic	2006	169
Discovery of Clinical Candidate 1-{[(2 <i>S</i> ,3 <i>S</i> ,4 <i>S</i> )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design Katherine L. Lee, Catherine M. Ambler, David R. Anderson, Journal of Medicinal Chemistry	2017	138
Convenient preparations of t-butyl esters and ethers from t-butanol Stephen W. Wright, David Hageman, Ann S. Wright, Tetrahedron Letters T-butyl EstersOrganic ChemistryChemistryDerivative (Chemistry)Synthetic Chemistry	1997	119
Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography Stephen W. Wright, Anthony Carlo, Maynard D. Carty, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryNovel Allosteric SiteAnilinoquinazoline InhibitorsAllosteric Inhibitors	2002	81
Rationally designed, potent competitive inhibitors of leukotriene biosynthesis E. J. Corey, John R. Cashman, Steven S. Kantner, Journal of the American Chemical Society J. CoreyMedicinal ChemistryPharmaceutical ScienceNatural Product SynthesisBiochemistry	1984	71
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases Brian S. Gerstenberger, Catherine M. Ambler, Eric P. Arnold, Journal of Medicinal Chemistry	2020	71
Reduction of the active-site iron by potent inhibitors of lipoxygenases Mark Nelson, Douglas G. Batt, Jeffery S. Thompson, Journal of Biological Chemistry Active-site IronBiological Inorganic ChemistryBiochemistryIron MetabolismMedicine	1991	60
Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists Shenping Liu, Leslie Dakin, Xing Li, Scientific Reports	2016	60
3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site Stephen W. Wright, Anthony Carlo, Dennis E. Danley, Bioorganic & Medicinal Chemistry Letters Cellular EnzymologyBiochemistryNatural SciencesBiocatalysisEnzyme Catalysis	2003	51

Page 1